Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes
- PMID: 16009891
- DOI: 10.1212/01.wnl.0000167546.39375.82
Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes
Abstract
Objective: To assess the prevalence, nature, and associated phenotypes of PINK1 gene mutations in a large series of patients with early-onset (<50 years) parkinsonism.
Methods: The authors studied 134 patients (116 sporadic and 18 familial; 77% Italian) and 90 Italian controls. The whole PINK1 coding region was sequenced from genomic DNA; cDNA was analyzed in selected cases.
Results: Homozygous pathogenic mutations were identified in 4 of 90 Italian sporadic cases, including the novel Gln456Stop mutation; single heterozygous truncating or missense mutations were found in another 4 Italian sporadic cases, including two novel mutations, Pro196Leu and Gln456Stop. Pathogenic mutations were not identified in the familial cases. Novel (Gln115Leu) and known polymorphisms were identified with similar frequency in cases and controls. In cases carrying single heterozygous mutation, cDNA analysis detected no additional mutations, and revealed a major pathogenic effect at mRNA level for the mutant C1366T/Gln456Stop allele. All patients with homozygous mutations had very early disease onset, slow progression, and excellent response to l-dopa, including, in some, symmetric onset, dystonia at onset, and sleep benefit, resembling parkin-related disease. Phenotype in patients with single heterozygous mutation was similar, but onset was later.
Conclusions: PINK1 homozygous mutations are a relevant cause of disease among Italian sporadic patients with early-onset parkinsonism. The role of mutations found in single heterozygous state is difficult to interpret. Our study suggests that, at least in some patients, these mutations are disease causing, in combination with additional, still unknown factors.
Comment in
-
Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes.Neurology. 2006 Apr 11;66(7):1129-30; author reply 1129-30. doi: 10.1212/01.wnl.0000220157.81513.85. Neurology. 2006. PMID: 16606941 No abstract available.
Similar articles
-
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.Neurology. 2007 May 8;68(19):1557-62. doi: 10.1212/01.wnl.0000260963.08711.08. Neurology. 2007. PMID: 17485642
-
Significance of the parkin and PINK1 gene in Jordanian families with incidences of young-onset and juvenile parkinsonism.BMC Neurol. 2008 Dec 16;8:47. doi: 10.1186/1471-2377-8-47. BMC Neurol. 2008. PMID: 19087301 Free PMC article.
-
Parkin and PINK1 mutations in early-onset Parkinson's disease: comprehensive screening in publicly available cases and control.J Med Genet. 2009 Jun;46(6):375-81. doi: 10.1136/jmg.2008.063917. Epub 2009 Apr 6. J Med Genet. 2009. PMID: 19351622 Free PMC article.
-
[Molecular genetics of PINK1].Brain Nerve. 2007 Aug;59(8):831-8. Brain Nerve. 2007. PMID: 17713119 Review. Japanese.
-
Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease.Mov Disord. 2012 Oct;27(12):1522-9. doi: 10.1002/mds.25132. Epub 2012 Sep 6. Mov Disord. 2012. PMID: 22956510 Review.
Cited by
-
Transgenic animal models of neurodegeneration based on human genetic studies.J Neural Transm (Vienna). 2011 Jan;118(1):27-45. doi: 10.1007/s00702-010-0476-6. Epub 2010 Oct 8. J Neural Transm (Vienna). 2011. PMID: 20931247 Free PMC article. Review.
-
Akt Phosphorylates NQO1 and Triggers its Degradation, Abolishing Its Antioxidative Activities in Parkinson's Disease.J Neurosci. 2019 Sep 11;39(37):7291-7305. doi: 10.1523/JNEUROSCI.0625-19.2019. Epub 2019 Jul 29. J Neurosci. 2019. PMID: 31358653 Free PMC article.
-
Cognitive Impairment in Genetic Parkinson's Disease.Parkinsons Dis. 2021 Dec 30;2021:8610285. doi: 10.1155/2021/8610285. eCollection 2021. Parkinsons Dis. 2021. PMID: 35003622 Free PMC article. Review.
-
A clinical and genetic study of early-onset and familial parkinsonism in taiwan: An integrated approach combining gene dosage analysis and next-generation sequencing.Mov Disord. 2019 Apr;34(4):506-515. doi: 10.1002/mds.27633. Epub 2019 Feb 20. Mov Disord. 2019. PMID: 30788857 Free PMC article.
-
Disruption of Mitochondrial Homeostasis: The Role of PINK1 in Parkinson's Disease.Cells. 2021 Nov 4;10(11):3022. doi: 10.3390/cells10113022. Cells. 2021. PMID: 34831247 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases